Physician profile
Jared Spencer
NPI 1548465834
$1,182.92
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $104 · 2021: $262 · 2022: $328 · 2023: $281 · 2024: $28.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $241.25 | 2019-2021 | |
| Intersect Ent, INC. | $223.45 | 2019-2022 | |
| Galderma Laboratories, L.P. | $206.17 | 2020-2024 | Dysport |
| Regeneron Healthcare Solutions, INC. | $160.39 | 2019-2023 | Dupixent, Libtayo |
| Acclarent, INC | $115.01 | 2019-2022 | |
| Karl Storz Endoscopy-America | $74.01 | 2022 | |
| Glaxosmithkline, LLC. | $33.53 | 2022-2023 | Bexsero, Rotarix |
| Merck Sharp & Dohme LLC | $32.64 | 2021-2023 | |
| Kaleo, INC. | $26.35 | 2019-2020 | |
| Csl Behring | $22.20 | 2023 | Kcentra |
| Medtronic, INC. | $19.41 | 2021 | |
| Abbvie INC. | $17.06 | 2023 | Botox |
| Allergan, INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.